| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0042-6822(92)90197-W |
| P698 | PubMed publication ID | 1329324 |
| P50 | author | Liyanage P Perera | Q88149362 |
| P2093 | author name string | W. T. Ruyechan | |
| J. Hay | |||
| J. D. Mosca | |||
| M. Sadeghi-Zadeh | |||
| Sadeghi-Zadeh M | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | trans-activators | Q67206335 |
| viral gene expression regulation | Q70682269 | ||
| immediate-early proteins | Q77944262 | ||
| promoter | Q224093 | ||
| P304 | page(s) | 346-354 | |
| P577 | publication date | 1992-11-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | The varicella-zoster virus immediate early protein, IE62, can positively regulate its cognate promoter | |
| P478 | volume | 191 |
| Q36650787 | A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domain. |
| Q36507994 | Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency |
| Q36397404 | An Sp1/Sp3 site in the downstream region of varicella-zoster virus (VZV) oriS influences origin-dependent DNA replication and flanking gene transcription and is important for VZV replication in vitro and in human skin |
| Q73393090 | Analysis of immune responses to varicella zoster viral proteins induced by DNA vaccination |
| Q41033506 | Cell type specific repression of the varicella zoster virus immediate early gene 62 promoter by the cellular Oct-2 transcription factor |
| Q36099097 | Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication |
| Q37515240 | Cellular transcription factor YY1 mediates the varicella-zoster virus (VZV) IE62 transcriptional activation |
| Q28315797 | Clinical and Molecular Pathogenesis of Varicella Virus Infection |
| Q40496550 | Combinatorial transcription of herpes simplex virus and varicella zoster virus immediate early genes is strictly determined by the cellular coactivator HCF-1. |
| Q39685724 | Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus |
| Q34436222 | Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype |
| Q45130208 | DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine |
| Q35101416 | Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells |
| Q36202693 | Differential effects of Sp cellular transcription factors on viral promoter activation by varicella-zoster virus (VZV) IE62 protein |
| Q38325198 | Distinct responses of the herpes simplex virus and varicella zoster virus immediate early promoters to the cellular transcription factors Brn-3a and Brn-3b |
| Q34545582 | Downregulation of varicella-zoster virus (VZV) immediate-early ORF62 transcription by VZV ORF63 correlates with virus replication in vitro and with latency |
| Q41177944 | Enhancement of varicella-zoster virus infection in cell lines expressing ORF4- or ORF62-encoded proteins |
| Q28474768 | Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor |
| Q92964769 | Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity |
| Q33900854 | Hydrophobic cluster analysis predicts an amino-terminal domain of varicella-zoster virus open reading frame 10 required for transcriptional activation |
| Q36655611 | Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge. |
| Q38553727 | Insights into the function of tegument proteins from the varicella zoster virus |
| Q45722653 | Interaction between the varicella zoster virus IE62 major transactivator and cellular transcription factor Sp1. |
| Q41332614 | Lessons to be learned from varicella-zoster virus |
| Q59793183 | Long-read sequencing uncovers a complex transcriptome topology in varicella zoster virus |
| Q33797830 | Modulation of major histocompatibility class II protein expression by varicella-zoster virus |
| Q59357897 | Molecular Aspects of Varicella-Zoster Virus Latency |
| Q40224871 | Mutation of a single lysine residue severely impairs the DNA recognition and regulatory functions of the VZV gene 62 transactivator protein |
| Q34434911 | Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region |
| Q36784535 | Mutational analysis of varicella-zoster virus (VZV) immediate early protein (IE62) subdomains and their importance in viral replication. |
| Q34746607 | Mutational analysis of varicella-zoster virus major immediate-early protein IE62. |
| Q43203463 | Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase |
| Q45733189 | Phosphorylation of varicella-zoster virus IE63 protein by casein kinases influences its cellular localization and gene regulation activity |
| Q35023792 | Promoter activation by the varicella-zoster virus major transactivator IE62 and the cellular transcription factor USF. |
| Q39698466 | Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo |
| Q35844037 | Proteins and cis-acting elements associated with transactivation of the varicella-zoster virus (VZV) immediate-early gene 62 promoter by VZV open reading frame 10 protein |
| Q36807601 | Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors |
| Q33769312 | Role of the IE62 consensus binding site in transactivation by the varicella-zoster virus IE62 protein |
| Q40584589 | Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus |
| Q40398718 | The DNA binding domains of the varicella-zoster virus gene 62 and herpes simplex virus type 1 ICP4 transactivator proteins heterodimerize and bind to DNA. |
| Q37567946 | The DNA element controlling expression of the varicella-zoster virus open reading frame 28 and 29 genes consists of two divergent unidirectional promoters which have a common USF site |
| Q45745359 | The TATA motif specifies the differential activation of minimal promoters by varicella zoster virus immediate-early regulatory protein IE62. |
| Q35846187 | The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection |
| Q36650274 | The transcriptional activation domain of varicella-zoster virus open reading frame 62 protein is not conserved with its herpes simplex virus homolog |
| Q35841513 | The transcriptional regulatory proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 63, but not ORF 61, are associated with purified virus particles. |
| Q35785127 | The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo |
| Q40359202 | Transactivation of the simian varicella virus (SVV) open reading frame (ORF) 21 promoter by SVV ORF 62 is upregulated in neuronal cells but downregulated in non-neuronal cells by SVV ORF 63 protein |
| Q40623905 | Transcription factor USF, expressed during the entire phase of varicella-zoster virus infection, interacts physically with the major viral transactivator IE62 and plays a significant role in virus replication |
| Q36634039 | Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63. |
| Q24656106 | Varicella-zoster virus (VZV) open reading frame 61 protein transactivates VZV gene promoters and enhances the infectivity of VZV DNA |
| Q35859868 | Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA |
| Q36994683 | Varicella-zoster virus IE62 protein utilizes the human mediator complex in promoter activation |
| Q40409988 | Varicella-zoster virus IE63 protein phosphorylation by roscovitine-sensitive cyclin-dependent kinases modulates its cellular localization and activity |
| Q33683365 | Varicella-zoster virus immune evasion |
| Q34545651 | Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo |
| Q36645576 | Varicella-zoster virus open reading frame 10 protein, the herpes simplex virus VP16 homolog, transactivates herpesvirus immediate-early gene promoters |
| Q36632309 | Varicella-zoster virus open reading frame 4 encodes a transcriptional activator that is functionally distinct from that of herpes simplex virus homology ICP27. |
| Q36630616 | Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27. |
| Q41337775 | Varicella-zoster virus open reading frame 66 protein kinase is required for efficient viral growth in primary human corneal stromal fibroblast cells. |
| Q28363307 | Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells |
| Q33845364 | Virion association of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, requires expression of the VZV open reading frame 66 protein kinase |
Search more.